Omnicell (OMCL) EBT Margin Growth (3y) (2013 - 2026)
Powered by 
Analysis
Omnicell (OMCL) EBT Margin Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | -429.00 |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 803.00 |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 260.00 |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 574.00 |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 764.00 |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 835.00 |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | -1,045.00 |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 598.00 |
| 9 | Resmed | 32.94 Bn | 31.47 Bn | 861.22 Mn | 773.00 |
| 10 | Omnicell | 1.57 Bn | 1.28 Bn | 152.94 Mn | 675.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 675.00 |
| Mar 31, 2026 | 1,274.00 |
| Dec 31, 2025 | 1,215.00 |
| Sep 30, 2025 | -185.00 |
| Jun 30, 2025 | 35.00 |
| Mar 31, 2025 | -509.00 |
| Dec 31, 2024 | 550.00 |
| Sep 30, 2024 | -375.00 |
| Jun 30, 2024 | -546.00 |
| Mar 31, 2024 | -1,237.00 |
| Dec 31, 2023 | -1,272.00 |
| Sep 30, 2023 | -266.00 |
| Jun 30, 2023 | 750.00 |
| Mar 31, 2023 | -1,222.00 |
| Dec 31, 2022 | -2,078.00 |
| Sep 30, 2022 | -529.00 |
| Jun 30, 2022 | -463.00 |
| Mar 31, 2022 | -405.00 |
| Dec 31, 2021 | -566.00 |
| Sep 30, 2021 | 69.00 |